We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 7.23%
2 Financials 5.58%
3 Industrials 4.98%
4 Consumer Discretionary 4.95%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSY
6501
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
$205K ﹤0.01%
23,100
-30,000
-56% -$310K
BFOR icon
6502
Barron's 400 ETF
BFOR
$239M
$204K ﹤0.01%
+20,596
New +$196K
DRIP icon
6503
CALL
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$99.5M
$204K ﹤0.01%
29
+6
+26% +$57.8K
ELS icon
6504
PUT
Equity Lifestyle Properties
ELS
$12.7B
$204K ﹤0.01%
+4,800
New +$209K
LXRX icon
6505
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
$204K ﹤0.01%
16,600
+2,200
+15% +$32.5K
OBE
6506
Obsidian Energy
OBE
$712M
$204K ﹤0.01%
27,805
-11,480
-29% -$85K
UHT
6507
Universal Health Realty Income Trust
UHT
$574M
$204K ﹤0.01%
+2,705
New +$209K
WCC
6508
PUT
WESCO International
WCC
$17.6B
$204K ﹤0.01%
3,500
-3,400
-49% -$183K
NTUS
6509
DELISTED
Natus Medical Inc
NTUS
$204K ﹤0.01%
5,452
-205,629
-97% -$7.26M
BF.A icon
6510
Brown-Forman Class A
BF.A
$13.3B
$203K ﹤0.01%
+4,548
New +$192K
CCK icon
6511
PUT
Crown Holdings
CCK
$12.9B
$203K ﹤0.01%
+3,400
New +$202K
CHD icon
6512
PUT
Church & Dwight Co
CHD
$24B
$203K ﹤0.01%
4,200
-8,500
-67% -$432K
CSTE icon
6513
CALL
Caesarstone
CSTE
$119M
$203K ﹤0.01%
6,800
-6,200
-48% -$194K
UDOW icon
6514
PUT
ProShares UltraPro Dow 30
UDOW
$924M
$203K ﹤0.01%
11,600
-28,400
-71% -$463K
XITK icon
6515
State Street SPDR FactSet Innovative Technology ETF
XITK
$73.4M
$203K ﹤0.01%
+2,620
New +$194K
CUTR
6516
PUT
DELISTED
Cutera, Inc.
CUTR
$203K ﹤0.01%
+4,900
New +$161K
USAK
6517
DELISTED
USA Truck Inc
USAK
$203K ﹤0.01%
+14,422
New +$146K
FNFV
6518
DELISTED
Fidelity Natl Financial, Inc.
FNFV
$203K ﹤0.01%
+11,865
New +$197K
AGEN
6519
Agenus
AGEN
$329M
$202K ﹤0.01%
2,331
-704
-23% -$57.1K
EBS icon
6520
CALL
Emergent Biosolutions
EBS
$235M
$202K ﹤0.01%
+5,000
New +$181K
PBD icon
6521
Invesco Global Clean Energy ETF
PBD
$195M
$202K ﹤0.01%
+15,940
New +$196K
VNET
6522
CALL
VNET Group
VNET
$2.16B
$202K ﹤0.01%
35,500
+4,200
+13% +$20.9K
WST icon
6523
CALL
West Pharmaceutical
WST
$24.6B
$202K ﹤0.01%
2,100
-2,200
-51% -$199K
LNCE
6524
PUT
DELISTED
Snyders-Lance, Inc.
LNCE
$202K ﹤0.01%
+5,300
New +$191K
OEUH
6525
DELISTED
OShares FTSE Europe Quality Dividend Hedged ETF
OEUH
$202K ﹤0.01%
7,532
-166
-2% -$4.43K

Similar funds

Ken Griffin's Q3 2017 Portfolio in Review

As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.